Real-time Estimate Cboe Europe 05:26:26 2024-05-17 am EDT 5-day change 1st Jan Change
80.15 CHF -0.90% Intraday chart for Alcon Inc. +9.08% +22.30%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 9.99B 9.07B Sales 2025 * 10.66B 9.68B Capitalization 44.19B 40.12B
Net income 2024 * 937M 851M Net income 2025 * 1.24B 1.12B EV / Sales 2024 * 4.7 x
Net Debt 2024 * 2.79B 2.53B Net Debt 2025 * 1.76B 1.6B EV / Sales 2025 * 4.31 x
P/E ratio 2024 *
48.8 x
P/E ratio 2025 *
39.2 x
Employees 25,000
Yield 2024 *
0.32%
Yield 2025 *
0.39%
Free-Float 98.58%
More Fundamentals * Assessed data
Dynamic Chart
1 day-0.98%
1 week+8.89%
Current month+12.71%
1 month+11.31%
3 months+17.13%
6 months+28.27%
Current year+22.09%
More quotes
1 week
73.90
Extreme 73.9
81.80
1 month
70.90
Extreme 70.9
81.80
Current year
62.24
Extreme 62.24
81.80
1 year
61.28
Extreme 61.28
81.80
3 years
55.22
Extreme 55.22
81.80
5 years
38.63
Extreme 38.625
81.80
10 years
38.63
Extreme 38.625
81.80
More quotes
Managers TitleAgeSince
Chief Executive Officer 58 16-06-30
Director of Finance/CFO 56 19-04-07
Chief Tech/Sci/R&D Officer - 11-05-31
Members of the board TitleAgeSince
Chairman 68 18-06-30
Director/Board Member 65 18-12-31
Director/Board Member 60 19-01-31
More insiders
Date Price Change Volume
24-05-17 80.3 -0.72% 401 970
24-05-16 80.88 +0.20% 1,061,568
24-05-15 80.72 +0.98% 1,491,145
24-05-14 79.94 +7.53% 3,037,635
24-05-13 74.34 +1.01% 1,084,336

Delayed Quote Swiss Exchange, May 17, 2024 at 04:01 am EDT

More quotes
Alcon Inc. is the global leader in the design, manufacture and marketing of ophthalmic care products. Net sales break down by category of products as follows: - ophthalmic surgical products and equipment (56.7%): consumables (51.2% of net sales), implantable products (32%) and other products (16.8%; in particular surgical equipment) for the treatment of cataracts, retinal diseases, glaucoma and refractive errors; - vision care products (43.3%): contact lenses (59.2% of sales) and eye care products (40.8%; eye drops and ophthalmic ointments, etc.) At the end of 2023, the group operated 19 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (0.7%), the United States (46%), Japan (6.2%), China (5.6%) and other (41,5%).
Calendar
More about the company
Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
28
Last Close Price
89.39 USD
Average target price
93.42 USD
Spread / Average Target
+4.51%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW